Alector to Participate in the TD Cowen 46th Annual Health Care Conference

Core Viewpoint - Alector, Inc. is actively participating in the TD Cowen 46th Annual Health Care Conference, highlighting its focus on developing therapies for neurodegenerative diseases [1]. Company Overview - Alector is a clinical-stage biotechnology company dedicated to counteracting neurodegeneration through innovative therapies [3]. - The company utilizes genetics, immunology, and neuroscience to advance its portfolio, which targets the removal of toxic proteins, replacement of missing proteins, and restoration of immune and nerve cell function [3]. - Alector's product candidates aim to address various neurodegenerative conditions, including Alzheimer's disease, Parkinson's disease, and frontotemporal dementia [3]. - The company is developing the Alector Brain Carrier (ABC), a proprietary platform designed to enhance therapeutic delivery across the blood-brain barrier, improving efficacy and patient outcomes while reducing costs [3]. Event Participation - Alector's management will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026, at 3:10 pm ET [1]. - A live webcast of the presentation will be available on Alector's website, with a replay accessible for 90 days post-event [2].